There is a small possibility one of the drug regimens helps. The lopinivir combos already has negative results in another trial. Same with remdesivir. The Hydroxychloroquine studies are poorly done.

They’re randomizing 650 people to each arm of the study so the data will be good. If there’s an early positive result we should here about it this week. I’m not holding my breath or buying stock in any of those companies.

I’d love to be proven wrong though.